1.
Survival of the unfittest: why the worst infrastructure gets built—and what we can do about it
by Flyvbjerg, Bent
Oxford review of economic policy, 2009, Vol.25 (3), p.344-367
2.
EVALUATING PUBLIC PROGRAMS WITH CLOSE SUBSTITUTES: THE CASE OF HEAD START
by Kline, Patrick
The Quarterly journal of economics, 2016-11-01, Vol.131 (4), p.1795-1848
3.
Does infrastructure investment lead to economic growth or economic fragility? Evidence from China
by Ansar, Atif
Oxford review of economic policy, 2016-10-01, Vol.32 (3), p.360-390
4.
Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil
by Fernandes, Eder Gatti
Vaccine, 2020-01-03, Vol.38 (1), p.46-53
5.
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer
by Siqueira, Paulo Gabriel
Vaccine, 2022-06-21, Vol.40 (28), p.3851-3860
6.
Ecology and Economics of Using Native Managed Bees for Almond Pollination
by Koh, Insu
Journal of economic entomology, 2017-12-19, Vol.111 (1), p.16-25
7.
Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015–2016
by Netanel, Carmit
Vaccine, 2021-11-26, Vol.39 (48), p.7101-7107
8.
Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand
by Hayman, D.T.S
Vaccine, 2017-09-05, Vol.35 (37), p.4913-4922
9.
Cost-benefit analysis of the use of tranexamic acid in total replacement hip surgery
by Lopez-Picado, Amanda
Journal of clinical anesthesia, 2019-11, Vol.57, p.124-128
10.
Approach to Economic Analysis in Critical Care
by Kyeremanteng, Kwadwo, MD, MHA, FRCPC
Journal of critical care, 2016, Vol.36, p.92-96
11.
Latin American Clinical Epidemiology Network Series – Paper 4: Economic evaluation of Kangaroo Mother Care: cost utility analysis of results from a randomized controlled trial cond...
by Ruiz, Juan Gabriel
Journal of clinical epidemiology, 2017-06, Vol.86, p.91-100
12.
The Impact of Twenty Four-Hour Public Transport in Melbourne, Australia: An Evaluation of Alcohol-Related Harms
by Curtis, Ashlee
Journal of studies on alcohol and drugs, 2019-05, Vol.80 (3), p.314-318
13.
Online Demand Under Limited Consumer Search
by Kim, J
Marketing science (Providence, R.I.), 2010-11, Vol.29 (6), p.1001-1023
14.
The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States
by Rothschild, Michael I
American journal of ophthalmology, 2015, Vol.168, p.110-121
15.
Cost-effectiveness of a community-based physical activity programme for adults (Be Active) in the UK: an economic analysis within a natural experiment
by Frew, Emma J
British journal of sports medicine, 2014-02, Vol.48 (3), p.207-212
16.
Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context
by Sartori, Ana Marli C
Vaccine, 2012, Vol.30 (52), p.7489-7497
17.
Cost–benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis...
by Cho, Sung-Yeon, MD
Clinical therapeutics, 2015, Vol.37 (9), p.2019-2027
18.
Costs and benefits of home care for the elderly versus residential care: a comparison using propensity scores
by Kok, Lucy
The European journal of health economics, 2014-01-04, Vol.16 (2), p.119-131
19.
The Life Satisfaction Approach to Valuing Public Goods: The Case of Terrorism
by Frey, Bruno S
Public choice, 2009-03-01, Vol.138 (3/4), p.317-345
20.
Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness
by Phelps, Charles, Ph.D
Vaccine, 2016, Vol.35, p.A46-A49
